1981
DOI: 10.1016/s0014-4835(81)80048-6
|View full text |Cite
|
Sign up to set email alerts
|

Plasma tryptophan in humans with diabetic and senile cataracts

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1981
1981
1996
1996

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 20 publications
(2 citation statements)
references
References 12 publications
0
2
0
Order By: Relevance
“…2) tryptophan plasma levels are increased in both diabetic and nonSupported by grants: EY 02905-02; Eli Lilly 724A-41-57806; NIH 724A-41-48178. diabetic humans with senile cataracts (7,9). Reducing the plasma levels of tryptophan or preventing increased tryptophan penetration into lens may slow down cataract formation.…”
Section: Introductionmentioning
confidence: 99%
“…2) tryptophan plasma levels are increased in both diabetic and nonSupported by grants: EY 02905-02; Eli Lilly 724A-41-57806; NIH 724A-41-48178. diabetic humans with senile cataracts (7,9). Reducing the plasma levels of tryptophan or preventing increased tryptophan penetration into lens may slow down cataract formation.…”
Section: Introductionmentioning
confidence: 99%
“…There is scant basic scientific evidence to explain such a protective effect. Acetylsalicylic acid has been found to lower plasma tryptophan (10), and plasma levels of tryptophan were found to be high in a group of patients with senile cataracts compared with a sample of patients with clear lenses (11)(12)(13).…”
Section: Discussionmentioning
confidence: 91%